Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Estrogen and related hormone effects, Prostate Cancer Treatment and Research, Breast Cancer Treatment Studies, and Advanced Breast Cancer Therapies.
A Deep Learning Approach for the Classification of Fibroglandular Breast Density in Histology Images of Human Breast Tissue.
JNK pathway suppression drives resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer
The transcription factor AP-2β defines active enhancers conferring molecular apocrine cell identity in breast cancer
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
Selective inhibition of CDK9 in triple negative breast cancer.
Androgen stimulation rapidly reorganizes temporal 3D genome and epigenome states to trigger AR-mediated transcription in prostate cancer
A Deep Learning Approach for Classification of Fibroglandular Breast Density in Histology Images of Human Breast Tissue
The molecular consequences of androgen activity in the human breast
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity.
Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen.
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians
Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer.
Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
The Androgen Receptor is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
Non-canonical AR activity facilitates endocrine resistance in breast cancer.
Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Androgen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial Cells.
A patient‐derived explant (<scp>PDE</scp>) model of hormone‐dependent cancer
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17
Progesterone receptor modulates ERα action in breast cancer